IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured human mesangial cells

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3451-3457

  Novak, Jan ^a   Raskova Kafkova, Leona ^a,i   Suzuki, Hitoshi ^a,b   Tomana, Milan ^c   Matousovic, Karel ^a,h   Brown, Rhubell ^a   Hall, Stacy ^a   Sanders, John T ^d   Eison, T Matthew ^d   Moldoveanu, Zina ^a   Novak, Lea ^e   Novak, Zdenek ^f   Mayne, Richard ^g   Julian, Bruce A ^a,c   Mestecky, Jiri ^a,c,h   Wyatt, Robert J ^d  

^a University of Alabama at Birmingham   (United States)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^e University of Alabama at Birmingham   (United States)

^f CHILDREN S HOSPITAL OF ALABAMA   (United States)

^g UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^h CHARLES UNIVERSITY   (Czech Republic)

ⁱ PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

autoimmunity; circulating immune complexes; glycosylation; immunoglobulin; O linked glycans

Indexed keywords

CREATININE; IMMUNOGLOBULIN A1; INTERLEUKIN 6; INTERLEUKIN 8; LAMININ; PHOSPHOTYROSINE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; FEMALE; GENE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATURIA; HUMAN; HUMAN CELL; IL 6 GENE; IL 8 GENE; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MESANGIUM CELL; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SCHOOL CHILD; SIGNAL TRANSDUCTION; URINALYSIS;

ADOLESCENT; ADULT; ANTIGEN-ANTIBODY COMPLEX; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GALACTOSE; GLOMERULAR FILTRATION RATE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MESANGIAL CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; YOUNG ADULT;

EID: 80155171873     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr448     Document Type: Article

References (40)

1. Berger J, Hinglais N. Les dépǒts intercapillaires d'IgA-IgG (Intercapillary deposits of IgA-IgG). J Urol Nephrol (Paris) 1968; 74: 694-695
2. Conley ME, Cooper MD, Michael AF. Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 1980; 66: 1432-1436
3. Julian BA, Novak J. IgA nephropathy: An update. Curr Opin Nephrol Hypertens 2004; 13: 171-179
4. Emancipator SN. IgA nephropathy and Henoch-Schönlein syndrome. In: Jennette JC, Olson JL, Schwartz MM, Silva FG, eds. Heptinstall's Pathology of the Kidney. Philadelphia, PA: Lippincott-Raven Publishers; 1998:479-539
5. Wyatt RJ, Julian BA, Baehler RW et al. Epidemiology of IgA nephropathy in central and eastern Kentucky for the period 1975 through 1994. J Am Soc Nephrol 1998; 9: 853-858
6. Sanders JT, Wyatt RJ. IgA nephropathy and Henoch-Schönlein purpura nephritis. Curr Opin Pediatr 2008; 20: 163-170
7. Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J Clin Lab Anal 1990; 4: 115-119
8. Mestecky J, Tomana M, Crowley-Nowick PA et al. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib Nephrol 1993; 104: 172-182
9. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin Exp Immunol 1995; 100: 470-474
10. Hiki Y, Horii A, Iwase H et al. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role. Contrib Nephrol 1995; 111: 73-84
11. Baharaki D, Dueymes M, Perrichot R et al. Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconj J 1996; 13: 505-511
12. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760-769
13. Tomana M, Matousovic K, Julian BA et al. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int 1997; 52: 509-516
14. Tomana M, Novak J, Julian BA et al. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 1999; 104: 73-81
15. Leung JCK, Poon PYK, Lai KN. Increased sialylation of polymeric immunoglobulin A1: Mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J Lab Clin Med 1999; 133: 152-160
16. Floege J, Feehally J. IgA nephropathy: Recent developments. J Am Soc Nephrol 2000; 11: 2395-2403
17. Novak J, Julian BA, Tomana M et al. Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 2001; 21: 310-327
18. Mestecky J, Novak J, Julian BA et al. Pathogenic potential of galactosedeficient IgA1 in IgA nephropathy. Nephrology 2002; 7: S92-S99
19. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int 2004; 65: 1544-1547
20. Kokubo T, Hiki Y, Iwase H et al. Exposed peptide core of IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 1999; 14: 81-85
21. Kokubo T, Hashizume K, Iwase H et al. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol Dial Transplant 2000; 15: 28-33
22. Suzuki H, Fun R, Zhang Z et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 2009; 119: 1668-1677
23. Czerkinsky C, Koopman WJ, Jackson S et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest 1986; 77: 1931-1938
24. Coppo R, Basolo B, Piccoli G et al. IgA1 and IgA2 immune complexes in primary IgA nephropathy and Henoch-Schönlein nephritis. Clin Exp Immunol 1984; 57: 583-590
25. Coppo R, Basolo B, Martina G et al. Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schönlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 1982; 18: 230-239
26. Allen AC, Bailey EM, Brenchley PEC et al. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int 2001; 60: 969-973
27. Hiki Y, Odani H, TakahashiMet al. Mass spectrometry proves under- O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 2001; 59: 1077-1085
28. Levinsky RJ, Barratt TM. IgA immune complexes in Henoch-Schönlein purpura. Lancet 1979; 2: 1100-1103
29. Novak J, Vu HL, Novak L, Julian BA et al. Interactions of human mesangial cells with IgA and IgA-containing circulating immune complexes. Kidney Int 2002; 62: 465-475
30. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 2005; 67: 504-513
31. Schwartz GJ, Haycock GB, Edelmann CM Jr. et al. A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 1976; 58: 259-263
32. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470
33. Haas M. Histologic subclassification of IgA nephropathy: A clinicopathologic study of 244 cases. Am J Kidney Dis 1997; 29: 829-842
34. Kerby JD, Verran DJ, Luo KL et al. Immunolocalization of FGF-1 and receptors in human renal allograft vasculopathy associated with chronic rejection. Transplantation 1996; 62: 467-475
35. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981; 29: 577-580
36. Suzuki H, Moldoveanu Z, Hall S et al. IgA1-secreting cell lines from patients with IgA nephropathy produce aberrantly glycosylated IgA1. J Clin Invest 2008; 118: 629-639
37. Duque N, Gomez-Guerrero C, Egido J. Interaction of IgA with Fca receptors of human mesangial cells activates transcription factor nuclear factor-jB and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10. J Immunol 1997; 159: 3474-3482
38. Moura IC, Arcos-Fajardo M, Gdoura A et al. Engagement of transferrin receptor by polymeric IgA1: Evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy. J Am Soc Nephrol 2005; 16: 2667-2676
39. Lai KN, Leung JC, Chan LY et al. Podocyte injury induced by mesangial-derived cytokines in IgA nephropathy. Nephrol Dial Transplant 2009; 24: 62-72
40. Coppo R, Fonsato V, Balegno S et al. Aberrantly glycosylated IgA1 induces mesangial cells to produce platelet-activating factor that mediates nephrin loss in cultured podocytes. Kidney Int 2010; 77: 417-427